Relacorilant + Nab-Paclitaxel vs Nab-Paclitaxel in Platinum-Resistant Ovarian Cancer: Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Exposure-Response

Presented: European Gynaecological Oncology Congress, 27 February 2026, Copenhagen, Denmark

Presenter: Nicoletta Colombo, M.D., Ph.D.


Scientific journal publications or scientific congress presentations may include information regarding investigational products or uses.

Download poster

© 2026 Corcept Therapeutics, Incorporated

Privacy Notice | Terms of Use | Site Map | Your Privacy Choices | LinkedIn | Youtube

Privacy Notice

Terms of Use

Site Map

Your Privacy Choices

LinkedIn

Youtube